About Ivbar
Ivbar is a company based in Stockholm (Sweden) founded in 2012 was acquired by LOGEX in October 2018. Ivbar has raised $5.73 million across 1 funding round from investors including LOGEX and Summa Equity. Ivbar operates in a competitive market with competitors including IQVIA, IntegriChain, Dental Intel, AVIA and Hublo, among others.
- Headquarter Stockholm, Sweden
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ivbar
Ivbar has successfully raised a total of $5.73M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.73 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ivbar
Ivbar has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LOGEX and Summa Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summa Equity is focused on thematic and impact investments.
|
Locked | Locked | Locked | |
|
Healthcare financial management solutions are developed for institutions and physicians.
|
Locked | Locked | Locked |
Investor details for Ivbar
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ivbar
Investment portfolio details for Ivbar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ivbar
Detailed financials for Ivbar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ivbar Comparisons
Peer comparison for Ivbar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ivbar
Ivbar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IQVIA, IntegriChain, Dental Intel, AVIA and Hublo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Dental intelligence is delivered via SaaS platform for performance analytics.
|
|
| Locked | Locked | Locked |
Digital platform for healthcare management and networking is offered.
|
|
| Locked | Locked | Locked |
Platform for hospitals to manage staff recruitments and replacements
|
|
| Locked | Locked | Locked |
Analytics platforms and consulting services for business intelligence are offered.
|
Detailed competitors of Ivbar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ivbar
Complete news archive for Ivbar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ivbar
Ivbar was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Ivbar is headquartered in Stockholm, Sweden.
Ivbar is a funded company, having raised a total of $5.73M across 1 funding round to date.
Ivbar was founded in 2012 in Stockholm, Sweden, within the healthcare analytics sector. A platform is operated to process patient and medical data from sources including records, claims, and systems. Benchmarking is facilitated among providers and health systems to identify improvement areas. Abnormal patient flows, process irregularities, non-profitable segments, and supplier performance are pinpointed, supporting outcomes enhancement and cost reduction for clinicians and management.
Ivbar's top competitors include IQVIA, AVIA and IntegriChain.
Ivbar has 2 investors. Key investors include LOGEX, and Summa Equity.